menu
    • menu

    Company profile for Serina Therapeutics

    NEW Drugs in Dev: 4
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Serina Therapeutics is a privately held biotechnology company situated in Huntsville, Alabama. The company has pioneered a proprietary and clinically validated polymer technology centered around the water-soluble polymer poly(oxazoline), referred to as POZ. This innovative POZ platform technology is engineered for programmable and targeted delivery of a diverse range of small molecules. Notably, Serina Therapeutics has clinica...
    Serina Therapeutics is a privately held biotechnology company situated in Huntsville, Alabama. The company has pioneered a proprietary and clinically validated polymer technology centered around the water-soluble polymer poly(oxazoline), referred to as POZ. This innovative POZ platform technology is engineered for programmable and targeted delivery of a diverse range of small molecules. Notably, Serina Therapeutics has clinically demonstrated the safety and efficacy of its technology, showcasing the ability to enable continuous drug delivery through a once-weekly subcutaneous injection.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Serina TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    601 Genome Way Suite 2001 Huntsville, Alabama 35806
    Telephone
    Telephone
    +1 2563270566
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://serinatherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/serina-therapeutics-inc./
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ELCC

    ELCC

    Not Confirmed

    envelop Contact Supplier

    ELCC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Serina Pharma Reveals 2025 Financials And Business Updates
    Serina Pharma Reveals 2025 Financials And Business Updates

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262599/0/en/Serina-Therapeutics-Reports-Full-Year-2025-Financial-Results-and-Recent-Business-Highlights.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    Serina Therapeutics To Present At The 38th Annual Roth Conference
    Serina Therapeutics To Present At The 38th Annual Roth Conference

    24 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/24/3261012/0/en/Serina-Therapeutics-to-Present-at-the-38th-Annual-Roth-Conference.html

    GLOBENEWSWIRE
    24 Mar 2026
    Share Share
    Serina Therapeutics Initiates Phase 1B Trial For SER-252
    Serina Therapeutics Initiates Phase 1B Trial For SER-252

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3244025/0/en/Serina-Therapeutics-Announces-Dosing-of-First-Patient-in-Phase-1b-Registrational-Trial-of-SER-252-for-Advanced-Parkinson-s-Disease.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share
    Serina Therapeutics Enrolls First Patient In SER-252 Phase 1B
    Serina Therapeutics Enrolls First Patient In SER-252 Phase 1B

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3240854/0/en/Serina-Therapeutics-Announces-First-Patient-Enrolled-in-Phase-1b-Registrational-Trial-of-SER-252-for-Advanced-Parkinson-s-Disease.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Tribe Public CEO Hosts Webinar For Presentation And Q&A Event
    Tribe Public CEO Hosts Webinar For Presentation And Q&A Event

    03 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/03/3230824/0/en/Registration-Is-Now-Open-For-Tribe-Public-s-CEO-Presentation-and-Q-A-Webinar-Event.html

    GLOBENEWSWIRE
    03 Feb 2026
    Share Share
    Serina Pharma Clears FDA IND For SER-252 In Advanced Parkinson
    Serina Pharma Clears FDA IND For SER-252 In Advanced Parkinson

    28 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/28/3228061/0/en/Serina-Therapeutics-Announces-FDA-Clearance-of-IND-Application-for-SER-252-for-the-Treatment-of-Advanced-Parkinson-s-disease.html

    GLOBENEWSWIRE
    28 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search